Cargando…
Dexamethasone intracameral drug-delivery suspension for inflammation associated with vitreoretinal surgery
OBJECTIVE: To evaluate the efficacy of an anterior chamber intracameral dexamethasone (ICD) drug-delivery suspension (Dexycu; EyePoint Pharmaceuticals, Watertown, Massachusetts, USA) providing sustained release of medication following a single application for the treatment of postoperative inflammat...
Autor principal: | Kiernan, Daniel F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228554/ https://www.ncbi.nlm.nih.gov/pubmed/32426525 http://dx.doi.org/10.1136/bmjophth-2020-000491 |
Ejemplares similares
-
Comparison of intracameral dexamethasone and intracameral triamcinolone acetonide injection at the end of phacoemulsification surgery
por: Güngör, Sirel Gür, et al.
Publicado: (2014) -
Comparison of intracameral dexamethasone and intracameral triamcinolone acetonide injection at the end of phacoemulsification surgery
por: Ozge, Gokhan, et al.
Publicado: (2015) -
Intracameral dexamethasone reduces inflammation on the first postoperative day after cataract surgery in eyes with and without glaucoma
por: Chang, Diane TW, et al.
Publicado: (2009) -
Intracameral dexamethasone injection in the treatment of cataract surgery induced inflammation: design, development, and place in therapy
por: Shah, Tirth J, et al.
Publicado: (2018) -
Safety of intracameral application of moxifloxacin and dexamethasone (Vigadexa®) after phacoemulsification surgery
por: Galvis, Virgilio, et al.
Publicado: (2023)